Regulatory issues discussed in Feb meet with US, Europe: DRL

The pharmaceutical sector, which is reeling under US FDA pressures, has addressed crucial regulatory issues in its February meet with US and European regulators, said Satish Reddy, Chairman of Dr Reddy’s Lab (DRL). Speaking to CNBC-TV18, Reddy said that the company will continue with tie-ups for biosimilar products. These will first be launched in India and then other markets, he added. DRL is looking for some tie-ups to launch biosimilar products in developed markets, he said.Watch video for the full interview..